Metrazifone
Names
[ CAS No. ]:
68289-14-5
[ Name ]:
Metrazifone
[Synonym ]:
as-Triazin-3(2H)-one,5,6-bis(p-(dimethylamino)phenyl)-2-methyl
Metrazifonum [INN-Latin]
5,6-bis-(4-dimethylamino-phenyl)-2-methyl-2H-[1,2,4]triazin-3-one
Metrazifone
Metrazifona
Metrazifona [INN-Spanish]
2-Methyl-3-oxo-5,6-di(paradimethylaminophenyl) as triazine
5,6-Bis(p-(dimethylamino)phenyl)-2-methyl-as-triazin-3(2H)-one
ST 729
Chemical & Physical Properties
[ Density]:
1.15g/cm3
[ Boiling Point ]:
497.1ºC at 760 mmHg
[ Molecular Formula ]:
C20H23N5O
[ Molecular Weight ]:
349.43000
[ Flash Point ]:
254.4ºC
[ Exact Mass ]:
349.19000
[ PSA ]:
54.26000
[ LogP ]:
2.64130
[ Index of Refraction ]:
1.607
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- XZ3018100
- CHEMICAL NAME :
- as-Triazin-3(2H)-one, 5,6-bis(p-(dimethylamino)phenyl)-2-methyl-
- CAS REGISTRY NUMBER :
- 68289-14-5
- BEILSTEIN REFERENCE NO. :
- 0564004
- LAST UPDATED :
- 199703
- DATA ITEMS CITED :
- 3
- MOLECULAR FORMULA :
- C20-H23-N5-O
- MOLECULAR WEIGHT :
- 349.48
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 43,407,1985
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >1 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 43,407,1985
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4188387